Industry Insights

The global breast lesion localization methods market size was valued at USD 507.7 million in the year 2016 and is estimated to reach a value of USD 1,577.6 million by 2025, growing at CAGR of 13.3%. Rising demand for better healthcare infrastructure and facilities as well as increasing awareness about mammary gland cancer screening are some of the key factors expected to boost the breast lesion localization methods market.

Various government and nongovernment organizations, such as American Cancer Society, Canadian Breast Cancer Foundation, and National Breast Cancer Foundation, have undertaken initiatives and have arranged diagnostic campaigns for mammary gland cancer detection. The National Breast Cancer Foundation has launched many programs such as Early Detection Plan and Breast Health Education to provide patients with facilities for early diagnosis and care services.

It was reported that around 252,710women & 2,470 men are expected to diagnose with invasive breast cancer and 40,610 women are expected to die from the condition in 2017. The survival rate in case of invasive type is 90% and 83% for five & ten years, respectively.

Mammary gland cancer surgery is an expensive procedure with its cost ranging from USD 8000 to 12000 for stage II and from USD 12000 to 18000 for stage III. The government has introduced favorable reimbursement policies to finance treatment and provide support to families of patients. For instance, the New York State Department of Health has launched an initiative called Cancer Services Program (CSP), which provides reimbursement for fine needle aspiration biopsy with ultrasound guidance. It also provides reimbursement for excisional biopsy, incisional biopsy, preoperative mammographic needle localization, and related services.

Type Insights

Breast lesion localization methods consist of various techniques such as wire localization biopsy, radioisotope localization, and magnetic tracers. Wire guided biopsy, also known as needle localization, is expected to dominate the market owing to its early development and higher adoption amongst end users. Widely used devices include RPLN, Duo System, Q-wire system, and X-Reidy.

Magnetic tracers are expected to witness fastest growth over the forecast period owing to their enhanced efficacy due to introduction of novel mechanisms. For instance, the combination of the instrument, Sentimag probe and the magnetic tracer, Sienna+ helps in accurate & safe procedure. Furthermore, cost-effectiveness, improved surgical planning, and enhanced workflow management support the growth of this segment.

The continuous technological advancements of lesion localization devices is also considered to be a key driver propelling the market growth. For instance, SAVI SCOUT of Cianna Medical, Inc. is a surgical guidance system that uses electromagnetic waves to detect a reflector placed at the target site up to seven days before surgery. In addition, SOMATEX has launched many advanced devices such as Tumark Q and Q-Wire System for localization of lesions.

Global breast lesion localization methods, by region, 2016 (%)

Regional Insights

North America is the dominant region of this market. It held the share of over 36.0% in 2016. Presence of key manufacturers in the U.S, established healthcare infrastructure, and high adoption of these procedures are some of the factors responsible for its large share. Moreover, favorable government initiatives and increasing number of breast conserving surgeries being performed are some of the drivers expected to fuel the market growth.

Asia Pacific is estimated to witness the fastest growth over the next decade with CAGR of around 15.0% owing to the rising disposable income, high unmet clinical needs of patients, rising awareness about early diagnosis, and availability of effective treatment in emerging countries, such as India and China.

Competitive Insights

Key players are focusing on expanding their businesses in developing regions to increase their market share. In addition, they are adopting strategies such as mergers & acquisitions and development of new products. For instance, in November 2015, SOMATEX launched new SXono needle guides. These needles provide guidance during tissue biopsies and follicular puncture.

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the market trends in each of the sub-markets from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the breast lesion localization methods market on the basis of type and region: